ReviewCombinatorial chemistry & high throughput screening2026
The Genus
Review in Combinatorial chemistry & high throughput screening, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Phytochemical small molecules fromAmerican journal of translational research · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe plants of genus Stauntonia DC. are important Chinese medicines. To better develop and utilize the edible and medicinal values of Stauntonia DC., the botany, phytochemistry, bioactivity, and application of genus Stauntonia DC. plants were summarized in this review.
methodsThe references of genus Stauntonia DC. were obtained from multiple databases, including ScienceDirect, Web of Science, Elsevier, SciFinder, PubMed, Willy, Baidu Scholar, Google Scholar, Scopus, SciHub, CNKI, and ancient classics on Chinese herbal medicine. The Latin names presented in the review are retrieved by the World Flora Online (http://www.worldfloraonline.org/) and the updated version of "The Plant List".
resultsA total number of 267 compounds were isolated from the plants of genus Stauntonia DC., which were classified as pentacyclic triterpenoids and their glycosides, methylated pentacyclic triterpenoids and their glycosides, phenylpropanoids, flavonoids, and so on. The bioactivities of genus Stauntonia DC. plants are diverse, including analgesic, anti-inflammatory, anti-cancer, hyperphilidemic, anti-oxidant, and other activities. The fruits from plants of genus Stauntonia DC. are edible, and seeds can be used for oil extraction.
conclusionThis review analysized and summarized the contents of botany, phytochemistry, bioactivity, application of genus Stauntonia DC. plants, which provided a comprehensive information resource for development and utilization of genus Stauntonia DC. plants.
Indexed as
Identifiers
40635208What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.